Your Trusted Source For HGH Therapy
Peptide therapy is a form of treatment that uses short chain of amino acids called peptide to give therapeutic effects by targeting multiple systems in the body. Human Growth Hormone (HGH) secretagogue is a type of peptide that helps increase growth hormone levels more naturally as compared to recombinant HGH (rhGH).
HGH is an important hormone that should not be passed by anyone who is interested in living longer and healthier life. It’s know as the repair hormone and plays a key role in the maintenance of a youthful appearance and healthy bodily functions. HGH also keeps you in a better mood, normalizes weight by increasing muscle mass and decreasing fat, gives you more energy, and helps you to think clearly.
Just like testosterone, HGH decreases beginning at age thirty. As we age, most of us in the have levels of HGH that are too low for optimal health. Without HGH, the body lack its ability to repair itself properly and goes downhill health-wise. Because of the high cost ($1,000-$2,000 per month) and strict legal environment surrounding the prescription of HGH, Alpha Hormones® recommend using peptide therapy instead. HGH secretagogues such as Sermorelin and Tesamorelin are generally safe and effective to treat suboptimal growth hormone levels.
Sermorelin is a synthetic peptide that was FDA-approved in 1997 for the diagnosis and treatment of growth hormone deficiency in children. It is a growth hormone–releasing hormone (GHRH) analog composed of the first 29 amino acids of endogenous GHRH. Because of this structure, Sermorelin stimulates the pituitary gland to produce and release growth hormone in a natural, physiologic pattern, which is why it is referred to as a “secretagogue.”
Sermorelin promotes the body’s own growth hormone production rather than supplying external hormone, and for this reason it is often considered a more physiologic alternative to exogenous HGH. Research has explored its potential to support metabolism, body composition, energy, and general wellness by encouraging healthy pituitary signaling, although individual responses can vary. It is important to note that many of the commonly discussed wellness or anti-aging applications of Sermorelin have not been established through large clinical trials, and these uses remain investigational.
As with any peptide therapy, Sermorelin should be used under the supervision of a licensed medical provider, with an understanding of its approved indications, potential risks, and limitations of current evidence.
Ipamorelin is a laboratory-developed peptide that has been studied for how it interacts with the body’s natural growth hormone system. It works by signaling the same receptor involved in normal growth hormone release, helping stimulate growth hormone in a pulsatile, physiologic pattern similar to how the body naturally functions.
Ipamorelin was researched in the late 1990s and early 2000s by the pharmaceutical company Novo Nordisk and was evaluated in FDA-regulated clinical trials for gastrointestinal motility conditions, including postoperative ileus. However, it was never approved by the FDA, and its development was later discontinued for commercial and strategic reasons rather than due to specific safety findings.
Compared with earlier growth hormone–releasing peptides studied historically, ipamorelin has been described in research as more selective in its activity, meaning it primarily targets growth hormone pathways rather than broadly affecting multiple hormones. In published studies, reported side effects were generally mild and transient, though individual responses varied.
In medical and scientific literature, ipamorelin is discussed in relation to growth hormone physiology, sleep regulation, tissue repair processes, metabolism, and age-related changes in hormone signaling. Research findings differ across studies and individuals, and investigation in this area continues.
Tesamorelin is an FDA-approved growth hormone–releasing factor (GRF) analog marketed under the brand name Egrifta®. It is approved specifically for the reduction of excess abdominal fat in HIV-infected patients with lipodystrophy. Tesamorelin works by stimulating the pituitary somatotroph cells to produce and release endogenous growth hormone in a pulsatile, physiologic manner. This increase in growth hormone subsequently elevates IGF-1 levels, which plays a role in metabolic regulation.
As a GRF analog, tesamorelin supports natural growth hormone secretion rather than supplying external hormone, and its effects on visceral adipose tissue have been demonstrated in its FDA-approved population. However, its use outside of the approved indication—including general weight loss, anti-aging, or wellness purposes—remains investigational. Patients considering tesamorelin for non-FDA-approved purposes should do so under the guidance of a licensed medical provider, with a full understanding of the therapy’s risks, limitations, and regulatory status.
Many patients pursue HGH secretagogues for their potential to support restorative sleep, daytime energy, cognitive function, and overall skin wellness. Individual responses vary, and these effects have not been established for all users or in all clinical settings. At Alpha Hormones®, our medical providers carefully review your health questionnaire, medical history, and laboratory results to understand your overall health profile and determine whether peptide therapy is appropriate for your needs, concerns, and goals.
Quality of Sleep
Recovery from workouts
Mental Clarity
Skin Elasticiy
Body Composition
HGH peptide therapy is a great way to increase your GH and IGF-1 levels. There are many benefits by optimizing HGH level, talk to the hormone expert and find out if this therapy is right for you.